Latest news
SKYSCRAPER-03 Trial: Critical Setback for TIGIT Consolidation in Stage III NSCLC - OncodailyOncodaily · Sat, 08 Aug 2026 11:36:12 GMTLiposomal Chemo Combination No Better Than Standard Induction in Pediatric AML - MedPage TodayMedPage Today · Fri, 07 Aug 2026 19:56:21 GMTVerrica Pharmaceuticals Q2 Earnings Call Highlights - TradingViewTradingView · Fri, 07 Aug 2026 19:04:20 GMTTrevi Therapeutics Q2 Earnings Call Highlights - TradingViewTradingView · Fri, 07 Aug 2026 18:04:23 GMTChina accepts NDA for Alebund's phosphate binder AP301 after Phase III success - AllSciAllSci · Fri, 07 Aug 2026 16:31:47 GMT‘Power Book III: Raising Kanan’ finale airs tonight: How to watch for free without cable - Syracuse.comSyracuse.com · Thu, 06 Aug 2026 23:30:00 GMTBezisterim meets motor and non-motor endpoints in phase II early Parkinson's trial. - AllSciAllSci · Thu, 06 Aug 2026 16:12:09 GMTDevelopers Initiate Phase 2/3 Ivonescimab/EV Trial in Bladder Cancer - CancerNetworkCancerNetwork · Thu, 06 Aug 2026 16:04:44 GMT